ANALYSES OF CERVICAL CANCER IN RAJKOT POPULATION

Similar documents
International Journal of Biological & Medical Research

Int. J. Life. Sci. Scienti. Res., 2(3): (ISSN: ) Impact Factor 2.4 MAY Research Article (Open access)

Clinical Practice Guidelines June 2013

Utility of Pap Smear in Cervical Screening in a Tertiary Care Hospital

Cervical Cancer Screening for the Primary Care Physician for Average Risk Individuals Clinical Practice Guidelines. June 2013

Department of Pathology, Kathmandu Medical College & Teaching Hospital, Sinamangal, Kathmandu, Nepal

Making Sense of Cervical Cancer Screening

UTILITY OF PAP SMEAR STUDY IN THE DIAGNOSIS OF VARIOUS NONN NEOPLASTIC LESIONS OF CERVIX.

Cervical Precancer: Evaluation and Management

Lesions of uterine cervix by cytology and histopathology- A prospective study for a period of two years

Study of cervical cytology in Papanicolaou (Pap) smears in a tertiary care hospital

WELL WOMAN CLINIC-SCREENING PROGRAM FOR CERVICAL CARCINOMAS G. J. Vani Padmaja 1

Study of Cervical Pap Smears in a Tertiary Hospital

Chapter 10: Pap Test Results

Study of PAP smear examination in patients complaining of leucorrhoea - A 2 years prospective study in a teaching hospital

International Journal of Health Sciences and Research ISSN:

Pap Smear and Histopathological Study of Cervical Lesions

Comparative Study of Pap Smear Quality by using Ayre s Spatula versus Ayre s Spatula and Cytobrush Combination

International Journal of Health Sciences and Research ISSN:

Uterine Cervical Smear Patterns In Females Attending A Teaching Hospital In Rural Eastern Uttar Pradesh, INDIA.

JMSCR Vol 07 Issue 02 Page February 2019

Appropriate Use of Cytology and HPV Testing in the New Cervical Cancer Screening Guidelines

Cytological Pattern of Cervical Smears in Leukorrhea

Eradicating Mortality from Cervical Cancer

Can LBC Completely Replace Conventional Pap Smear in Developing Countries

BC Cancer Cervix Screening 2015 Program Results. February 2018

Cervical Cancer : Pap smear

Objectives. I have no financial interests in any product I will discuss today. Cervical Cancer Screening Guidelines: Updates and Controversies

HPV Testing & Cervical Cancer Screening:

Histopathological Correlation with Cervical Cytology

GUIDELINE FOR SCREENING FOR CERVICAL CANCER: REVISED

Spectrum of Cervical Cytological Lesions in Premenopausal and Postmenopausal Women

Clinically Microscopically Pathogenesis: autoimmune not lifetime

Dysplasia: layer of the cervical CIN. Intraepithelial Neoplasia. p16 immunostaining. 1, Cervical. Higher-risk, requires CIN.

Role of cytology, colposcopy and colposcopic directed biopsy in the evaluation of unhealthy cervix

Cervicovaginal Cytology: Normal and Abnormal Cells and Adequacy of Specimens

Cervical Cancer Screening Update. Melissa Hartman, DO Women s Health

HPV & CERVICAL CANCER POLICY & LEGISLATIVE TOOLKIT, 3 RD EDITION

A Study on Diagnostic Accuracy of Cervical Pap Smear by Correlating with Histopathology in a Tertiary Care Centre

January 15, 2009 (202) PROPOSALS TO IMPROVE CYTOLOGY PROFICIENCY TESTING REQUIRED BY THE CLINICAL LABORATORY IMPROVEMENT AMENDMENTS OF 1988

Cervical cytology by pap smear in reproductive population

Case Based Problems. Recommended Guidelines. Workshop: Case Management of Abnormal Pap Smears and Colposcopies. Disclosure

Workshop for O& G trainees and paramedics 17 Dec 2011 Cytological Interpretation

Associate Professor of Gyn. & Obs., Department of Gynecology and Obstetrics, Tehran University of Medical Sciences, Iran.

Colposcopy. Attila L Major, MD, PhD

PREVENTION OF CERVICAL CANCER

Cervical Screening for Dysplasia and Cancer in Patients with HIV

CERVIX. MLS Basic histological diagnosis MLS HIST 422 Semester 8- batch 7 L12 : Dr. Ali Eltayb.

A Study on Cervical Pap Smear Examination in Patient Living with HIV.

Profile Of Cervical Smears Cytology In Western Region Of Saudi Arabia

Detection Of Abnormal Cervical Cytology In Papanicolaou Smears At A Tertiary Care Hospital

Cervical Testing and Results Management. An Evidenced-Based Approach April 22nd, Debora Bear, MSN, MPH

JMSCR Vol 06 Issue 11 Page November 2018

Samuel B. Wolf, D.O., F.A.C.O.G. Emerald Coast Obstetrics and Gynecology Panama City Florida

Cytopathology. Robert M Genta Pathologie Clinique Université de Genève

PAP SMEAR WITH ATYPICAL SQUAMOUS CELLS OF UNDETERMINED SIGNIFICANCE

PAP smear. (Papanicolaou Test)

Understanding Your Pap Test Results

Case Study 1. Cervical Cancer Screening and Sexually Transmitted Infections Case Studies

International Journal of Health Sciences and Research ISSN:

Pap smear cytological findings in women with abnormal visual inspection test results referred to Kenyatta National Hospital

Cervical Skills. Dr Margaret Laing Queen Elizabeth University Hospital

Cervical Dysplasia and HPV

The ABCs of TBS. A Novice's Guide to the Bethesda System

Lessons From Cases of Screened Women Who Developed Cervical Carcinoma

PRE TEST CERVICAL SCREENING MANAGEMENT COLPOSCOPY PATHOLOGIC DIAGNOSIS AND TREATMENT

I have no financial interests in any product I will discuss today.

I have no financial interests to disclose.

Comparison of RR100, R10 and morphologic guided list criteria in rescreening of 4000 cervical smears an experience in a tertiary care hospital

PAP SMEAR by Dr.Shantha Krishnamurthy MD Senior Consultant Pathology Fortis Hospitals

INTRODUCTION HSIL AND CERVICAL CARCINOMA IN ASCUS CERVICAL CYTOLOGY

EU guidelines for reporting gynaecological cytology

Study Number: Title: Rationale: Phase: Study Period Study Design: Centres: Indication Treatment: Objectives: Primary Outcome/Efficacy Variable:

Faculty Pap Smear Guidelines: Family Planning Update 2008 Part Two

JMSCR Vol 05 Issue 03 Page March 2017

What is a Pap smear?

I have no financial interests in any product I will discuss today.

Cervical Cancer Screening with Cytology and Colposcopy in Rural Medical College Hospital of Himachal Pradesh, India

STUDY OF EARLY DETECTION OF CERVICAL CANCER BY PAP S SMEAR IN SELECTED SETTING OF PUDUCHERRY

Epidemiologic Study of Colposcopy in Clinical Centers of Kermanshah, Iran, during 2006 to 2011

Pattern of Pap smear Cytology and Its Histopathological Correlation at a Tertiary Care Center

The Korean Journal of Cytopathology 13(1): 14-20, 2002

Clinical Usefulness of Cervicogram as a Primary Screening Test for Cervical Neoplasia

AgNOR Count and its Correlation with Colposcopy in Suspicious Cervix

Department of Health Standard for the Cervical Cancer Screening Program. Approval Date: 08 May 2018 Effective Date: 13 May 2018

Effect of human papillomavirus vaccination on cervical cancer screening in Alberta

TISSUE TUMOR MARKER EXPRESSION IN

What is cervical cancer?

A cyto-histopathological correlation study of lesions of uterine cervix

Cervical cancer screening with pattern of pap smear. Review of multicenter studies. Fadwa J. Altaf, FRCPC, F.I.A.C. ABSTRACT

HKCOG GUIDELINES NUMBER 3 (revised November 2002) published by The Hong Kong College of Obstetricians and Gynaecologists

Screening for Cervical Cancer: Demystifying the Guidelines DR. NEERJA SHARMA

Prevalence of cervical cancer and role of screening programmes by PAP smears

SESSION J4. What's Next? Managing Abnormal PAPs in 2014

Should Anal Pap Smears Be a Standard of Care in HIV Management?

X-Treme Primary Care: HPV and STIs. Arti Barnes MD MPH Clinical Director South Central AIDS Education and Training Centers

Name of Policy: Speculoscopy

Diagnostic value of VIA comparing with conventional pap smear in the detection of colposcopic biopsy proved CIN

Understanding My Pap Test Results

Acceptable predictive accuracy of histopathology results by colposcopy done by Gynecology residents using Reid index

Transcription:

Electronic Journal of Pharmacology and Therapy Vol 4, 15-20 (2011) ISSN: 0973-9890 (Available online at wwwtcrjournalscom) Clinical Article ndexed in: ProQuest database Abstract, USA (ProQuest Science Journals, Health and Medical complete), EBSCO databases (USA), Indian Science Abstract, Medical and Aromatic Plant Abstract, New Delhi ANALYSES OF CERVICAL CANCER IN RAJKOT POPULATION DHRUVA, G A, AGRAVAT, A H, AND BHOJANI, K R Department of Pathology, Pandit Deendyal Upadhya Medical College, Rajkot 360 005 E mail: gadhruva@gmailcom Received: July10, 2011; Accepted: August 11, 2011 Abstract: Cervical malignancy is the second most common cancer in women worldwide, In present study, results of 400 Pap smears are analyzed, which had been examined in cytology section (Department of Pathology, PDU Medical College, Rajkot) during 2 years time duration (2009-2010) All cervical smears collected and stained by Pap staining method The smears were reported using The Bethesda system 2001 The commonest complaints observed during study were abnormal vaginal discharge (465%) and menstrual abnormalities (205%) According to classification of smears by Bethesda system, 18(45%) were unsatisfactory, 148(37%) were normal, 07(125%) had atrophic changes, 190(475%) were inflammatory, 03(075%) were ASCUS, 20(5%) were LSIL, 11(275%) were HSIL and 03(075%) were squamous cell carcinoma, majority patients had 2 children 144(36%) and study showed that high parity was associated with higher occurrence of premalignant and malignant lesions of cervix Pap smear is a simple, cheap, safe and practical diagnostic tool for early detection of cervical cancer in high risk group population and therefore should be established as routine screening procedurepap smear is a valuable tool for investigation as a screening procedure in asymptomatic women and as a diagnostic procedure in symptomatic womenit also has an important role in diagnosis of inflammatory lesions including the identification of causative organism, atrophic changes, changes of radiation therapy and some rare tumorsit is recommended that reporting should be done by The Bethesda System as it improves the reproducibility and helps in identification of ASCUS and AGUS lesions and plays a key role to diagnose various intraepithelial lesions and invasive lesions at an early stage and manage them properly Key words: Cervical smears, Pap stain, Bethesda? INTRODUCTION Cervical malignancy is the second most common cancer in women worldwide following breast cancer, and the leading cause of death by cancer It is one of the most preventable and curable of all cancers The Papanicolaou smear is most useful tool for detection of abnormal cells that may be due to preneoplastic lesions or frank malignancy The test is named after Dr George Papanicolaou who introduced it in 1941[1] The easy accessibility of the cervix and the propensity of the cancer cells to exfoliate from its surface have enabled us to study the process of malignant transformation in the cervix in very early stage [2] Currently Pap test has gained wide popularity not only as a diagnostic test in patients but also 15

as an important routine screening test in asymptomatic women due to its simplicity and cost effectiveness [3] MATERIAL AND METHODS In present study, results of 400 Pap smears are analyzed,which had been examined in cytology section (Department of Pathology, PDU Medical College, Rajkot) during 2 years time duration (2009-2010) All of the patients had some relevant gynecological complaints who presented to gynecology OPD The age of the screened patients was in the range of 18-80 years Cervical smears were collected by gynecologist with plastic spatula [4] All cervical smears collected were fixed by 100% methanol and stained by Pap staining method [5]The relevant clinical data were collected by gynecologists, including the exact day of menstrual cycle, age of patients, parity, presenting symptoms etc,history had been elicitedthe smears were reported using the Bethesda system 2001 [6-8] RESULTS In present study, results of 400 Pap smears are analyzed, which had been examined in cytology section (Department of Pathology, PDU Medical College, Rajkot) during 2 years (2009-2010) The commonest complaints observed during study were abnormal vaginal discharge (465%) and menstrual abnormalities (205%) (Table 1) According to classification of smears by Bethesda system, 18 (45%) were unsatisfactory, 148(37%) were normal, 07(125%) had atrophic changes, 190(475%) were inflammatory, 03(075%) were ASCUS, 20(5%) were LSIL, 11(275%) were HSIL and 03(075%) were squamous cell carcinoma The commonest lesion was inflammatory, followed by squamous intraepithelial neoplasia and squamous cell carcinoma (Table 2) Overall incidence of inflammatory lesions was highest in 2 nd decade followed by 3 rd decade E JPharmacol Therapy 16 Out of 190 cases of inflammatory smears, there were 143(36%) cases of acute cervicitis, 39(975%) cases of chronic cervicitis,02(05%) cases of Trichomomas vaginalis, 01(025%) cases of Bacterial vaginosis, 03(075%) cases of Candidiasis and 03(075%) cases of Herpes simplex virus (Table 3) ASCUS incidence was highest in 5 th decadeincidence of LSIL, HSIL and Squamous cell carcinoma were highest after 6 th decade (Table 4) Table 1: Distribution of patients according to symptoms No symptoms Noof patients Percentage (n=400) (%) 1 Discharge 186 465 2 Menstrual abnormalities 82 205 3 Lower abdominal pain 38 95 4 Backache 23 575 5 Post coital bleeding 21 525 6 Infertility 08 2 7 Post menopausal bleeding 07 175 8 Other complains 35 875 Total 400 100 Table- 2: Distribution of patients according to cytopathological findings No Finding No of Percentage patients (%) (n=400) Inflammatory changes 1 Acute inflammation 143 36 2 Chronic inflammation 39 975 3 Trichomonas vaginalis 02 05 4 Bacterial vaginosis 01 025 5 Actinomycetes 00 00 6 Candida 02 05 7 Herpes simplex virus 03 075 Total inflammatory smears 190 475 Epithelial abnormalities 8 ASCUS 03 075 9 ASCH 00 00 Low grade squamous intraepithelial 10 lesions (LSIL) 20 5 High grade squamous 11 intraepithelial 11 275 lesions(hsil) 12 Squamous cell carcinoma 03 075 13 Any glandular lesions 00 00 Total No of smears showing epithelial abnormalities 37 925 TOTAL 400 100

Age group (years) Acute inflammation Dhruva et al Table 3: Age wise distribution of inflammatory smears (Figures in the bracket indicates percentage of the lesions in the respective age group) Chronic inflammation Trichomonas vaginalis Bacterial vaginosis Candida Herpes simplex virus Total <20 05 02 (40) 00 00 01 (20) 00 00 03 (60) 20-29 97 51 (5257) 11(114) 01 (103) 00 00 01 (103) 64 (6597) 30-39 139 58 (4172) 14 (1007) 01 (071) 00 01 (071) 00 74 (5321) 40-49 82 21 (2560) 08 (975) 00 00 01 (121) 01 (121) 31 (3780) 50-59 42 06 (1428) 03(714) 00 00 00 01 (238) 10 (2380) >60 35 05 (1428) 03 (857) 00 00 00 00 08 (2225) Total 400 143 39 02 01 02 03 190 Table 4: Age wise distribution of squamous epithelial cell abnormalities (Figures in the bracket indicates percentage of the lesions in the respected age group) Squamous cell Total Age group (years) ASCUS LSIL HSIL Carcinoma <20 05 00 00 00 00 00 20-29 97 00 01(103) 00 00 01(103) 30-39 139 00 03(215) 02(144) 00 05(359) 40-49 82 01(121) 08(975) 04(487) 01(121) 14(1707) 50-59 42 02(476) 03(714) 02(476) 01(238) 08(1904) >60 35 00 05(1428) 03(857) 01(285) 09(2571) Table-5: Distribution of epithelial abnormalities according to Parity (Figures in the bracket indicates percentage of the lesions in the respective age group) Parity ASCUS LSIL HSIL Squamous cell Carcinoma Total Nulliparous 35 00 00 00 00 00 Para I 118 00 04(338) 02(169) 00 06(508) Para II 144 02(138) 07(486) 04(277) 01(069) 14(972) Para III and above 103 01(097) 09(873) 05(485) 02(194) 17(1650) Regarding parity, majority patients had 2 children 144(36%) and study showed that high parity was associated with higher occurrence of premalignant and malignant lesions of cervix (Table 5) Regarding the religion of the patients 317(7925%) were Hindus and 83(2075%) were Muslims No any significant difference observed in the incidence of epithelial abnormalities in both religions (Table 6) Regarding locality of the patients majority of the patients 176(44%) were from rural area, 155(3875%) were urban slum and 69(1725%) urban area Incidence of preneoplastic and neoplastic lesions was highest in patients residing in urban slum areas (Table 7) Early age(<18 years) at first sexual intercourse is found to associated with more chances of development of premalignant and malignant lesions of the cervix (Table 8) 17

E JPharmacol Therapy Table 6: Distribution of epithelial abnormalities according to Religion (Figures in the bracket indicates percentage of the lesions in the respective age group) Religion ASCUS LSIL HSIL Squamous cell carcinoma Total Hindu 317 02(063) 16(504) 08(252) 03(094) 29(914) Muslim 83 01(120) 04(481) 03(361) 00 08(963) Table 7: Distribution of epithelial abnormalities according to locality (Figures in the bracket indicates percentage of the lesions in the respective age group) Locality ASCUS LSIL HSIL Squamous cell Carcinoma Total Urban 69 00 01(144) 02(289) 00 03(434) Urban Slum 155 02(129) 09(580) 05(322) 02(129) 18(1161) Rural 176 01(056) 10(568) 04(227) 01(056) 16(909) Table 8: Distribution of patients according to age at first sexual intercourse No Age at first sexual intercourse (years) No of Patients (%) 1 <18 117(2925) 2 18-25 245(6125) 3 >25 38(95) Total 400(100) Incidence of both inflammatory lesions and epithelial abnormalities are higher in HIV positive women as compared to HIV negative woman (Table 9) DISCUSSION AND CONCLUSIONS Pap smear is a simple, cheap, safe and practical diagnostic tool for early detection of cervical cancer in high risk group population and therefore should be established as routine screening procedure Pap smear is a valuable tool for investigation as a screening procedure in asymptomatic women and as a diagnostic procedure in symptomatic women It also has an important role in diagnosis of inflammatory lesions including the identification of causative organism, atrophic changes, changes of radiation therapy and some rare tumors It is recommended that reporting should be done by The Bethesda System as it improves the reproducibility and helps in identification of ASCUS and AGUS lesions and plays a key role to diagnose various intraepithelial lesions and invasive lesions at an early stage and manage them properly High incidences of squamous cell abnormalities are found in patients from urban slum and rural areas, multiparous patients and in patients with younger age at first coitus All suspicious lesions on Pap smears should be followed by repeat Pap smear examination, colposcopy or cervical biopsy Health awareness programs particularly by Media and Government with their implementation in the form of screening camps would be a great help to women particularly in rural and urban slum areas Abbrevations used in text: ASCUS-Atypical squamous cells of undetermined significance ASC-H-Cannot exclude HSILLSIL-Low grade squamous intraepithelial lesion HSIL-High grade squamous intraepithelial lesions SCC- Squamous cell carcinomaagcus-atypical glandular cell of undetermined significance 18

Dhruva et al Fig 1: Trichomonas vaginalis (40 ) Fig 3: HPV related changes-perinuclear halo[lsil]( 40 ) Fig2: Candida albicans showing branching hyphae( 40 ) Fig 4: High grade squamous intraepithelial lesion [HSIL] ( 40 ) Fig5: Squamous cell carcinoma(40 ) 19

E JPharmacol Therapy Table 9: Cytopathological findings in HIV positive patients No Finding No of patients(n=19) Percentage(%) Inflammatory changes 1 Acute inflammation 10 5263 2 Chronic inflammation 02 1052 3 Trichomonas vaginalis 00 00 4 Bacterial vaginosis 00 00 5 Actinomycetes 00 00 6 Candida 01 526 7 Herpes simplex virus 01 526 Epithelial abnormalities 8 ASCUS 00 00 9 ASCH 00 00 10 Low grade squamous intraepithelial lesions (LSIL) 03 1578 11 High grade squamous intraepithelial lesions(hsil) 02 1052 12 Squamous cell carcinoma 00 00 13 Any glandular lesions 00 00 Total No of smears showing epithelial abnormalities 05 Total 19 100 REFERENCES [1] Papanicolaou, GN: Am J Clin Path, 19: 301-308 (1940) [2] Papanicolaou, GN and Traut, HF: Am J Obstet Gynecol, 42: 193-205 (1941) [3] Koss, LG: Acta Cytol, 29(7): 1193-1197 (1990) [4]Lucille, M, Marlon, M, Gail, K and Sonia, CA: Wisconsin Med J, 104(06): 51-55 (2005) [5] Bancroft, JD and Cook, HC: Manual of Histological Techniques and Their Diagnostic Application Churchill Livingstone pub, pp 325-326 (1994) [6] Solomaon, D: JAMA, 262(7): 931-934 (1989) [7] Wright, TC, Ferenczy, AF and Kurman, RJ: JAMA, 287(16): 2120-2129 (2002) [8] Leopold, GK, Myron, RM: Koss Diagnostic Cytology and its Histopathologic Bases Lippincott Willims and Wilkins pub, 5 th Edi Vol 1, pp 186-190 (2006) 20